Delivery Order SPE2D018D0005-SPE2D324F1098

Award Date 11/6/23
Potential Completion Date 11/9/23
Potential Value $1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Ortho-Clinical Diagnostics Inc. was awarded a $1,037.23 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 150ml of monoclonal anti-D reagent to be delivered to Raritan, New Jersey by November 9, 2023. No set-aside designation was applied to this solicitation. Ortho-Clinical Diagnostics holds several indefinite delivery vehicles with federal healthcare agencies to supply critical laboratory equipment, reagents, and blood bank services in support of...
Ortho-Clinical Diagnostics Inc. has been awarded a $1,037.23 firm fixed price delivery order against an unidentified contract vehicle by the Defense Logistics Agency Troop Support Medical to provide 4561341953, described as 150ml vials of monoclonal anti-D reagent, for use at a place of performance in Raritan, New Jersey. The delivery order has a period of performance from June 26, 2023 through June 29, 2023 to supply the specified medical reagents to the Department of Defense logistics...
Ortho-Clinical Diagnostics Inc. was awarded a $1,037.23 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 150ml of monoclonal anti-D reagent to the agency. The place of performance will be the prime contractor's facility located in Raritan, New Jersey. The firm fixed price order has a period of performance from September 25, 2023 through September 28, 2023 to deliver the requested medical supplies in support of...
Ortho-Clinical Diagnostics Inc. was awarded a $5,186.15 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 150ml of monoclonal anti-D reagent to the agency. The place of performance will be the prime contractor's facility located in Raritan, New Jersey. The period of performance is short, spanning from June 28 to July 3, 2023. This firm-fixed-price order supports the agency's medical supply needs and will...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order for $5,186.15 to Ortho-Clinical Diagnostics Inc. for the purchase of 150 ML of REAGENT ANTI-D BIOCLONE. Ortho-Clinical Diagnostics Inc. is a medical equipment manufacturer that provides a range of diagnostic solutions, including immunodiagnostic and clinical chemistry systems, to federal agencies such as the Department of Veterans Affairs and Department of Health and Human Services. This delivery order...
The Defense Logistics Agency Troop Support Medical awarded a $1,037.23 firm fixed-price delivery order to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, for the supply of 150 mL Bioclone anti-D reagent. This order is not associated with any set-aside designation. Ortho-Clinical Diagnostics is a for-profit organization that has previously provided a variety of medical equipment, reagents, and services to federal agencies such as the Department of Veterans Affairs, Defense...
Ortho-Clinical Diagnostics Inc. was awarded a $1,878.12 delivery order against an indefinite-delivery contract held with the Defense Logistics Agency Troop Support Medical. The order is for RH-HR Control 15x10ml and will be fulfilled from the contractor's facility in Raritan, NJ by November 9, 2023. As a manufacturer of medical diagnostic equipment and reagents, Ortho-Clinical Diagnostics supports various federal healthcare programs through multiple blanket purchase agreements and indefinite...
The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order contract to Ortho-Clinical Diagnostics, Inc. for $1,037.23 to provide 150 ml of Reagent Anti-D Bioclone. Ortho-Clinical Diagnostics is a manufacturer of medical equipment and diagnostic solutions that has provided products and services to various federal agencies, including the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service. This delivery order is not associated with a...
Ortho-Clinical Diagnostics Inc. was awarded a $1,878.12 delivery order against an indefinite-delivery contract held with the Defense Logistics Agency Troop Support Medical. The delivery order is for RH-HR Control 15x10ml with performance at the awardee's facility in Raritan, New Jersey and a completion date of November 9, 2023. As a manufacturer of medical equipment and diagnostics, Ortho-Clinical Diagnostics provides critical analyzers, reagents, and blood bank services to various federal...
Ortho-Clinical Diagnostics Inc. was awarded a $43,040 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. The prime contractor will provide approximately 10 ml of anti-IgG reagent to the agency over a three-day period of performance in August 2023. The firm fixed price order was awarded to Ortho-Clinical Diagnostics Inc. for supply of the specified medical reagent to support the Defense Logistics Agency Troop Support...
  • SPE2D018D0005
    Indefinite Delivery Contract
  • SPE2D018D0005-SPE2D324F1098
    Delivery Order

Ortho-Clinical Diagnostics Inc. has been awarded a $1,037.23 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 150ml of monoclonal anti-D reagent to be delivered to Raritan, New Jersey by November 9, 2023. This delivery order was issued against indefinite-delivery vehicles Ortho-Clinical Diagnostics holds to supply critical laboratory equipment, reagents, and blood bank services in support of federal healthcare programs including the Department of Defense. No set-aside designation was applied to this award made to the medical equipment manufacturer for the specified reagents.

Generated 2/5/24, 9:34 AM